2007 Vol.25, N°5 - Suppl.46 - Table of contents
Abatacept: selective T cell co-stimulation modulation in the management of rheumatoid arthritis
Guest Editors: J.S. Smolen, M. Schiff
Full Papers
CER3099
2007,25,5,Suppl.46
Pg. 0004-0011
Free to view
The central role of T cells in rheumatoid arthritis
A.P. Cope, H. Schulze-Koops, M. Aringer
A.P. Cope, H. Schulze-Koops, M. Aringer
CER3100
2007,25,5,Suppl.46
Pg. 0012-0021
Free to view
The evolution of the immunobiology of co-stimulatory pathways: clinical implications
S. Trikudanathan, M.H. Sayegh
S. Trikudanathan, M.H. Sayegh
CER3101
2007,25,5,Suppl.46
Pg. 0022-0029
Free to view
Disease activity measures for rheumatoid arthritis
M. Dougados, D. Aletaha, P. van Riel
M. Dougados, D. Aletaha, P. van Riel
CER3102
2007,25,5,Suppl.46
Pg. 0030-0034
Free to view
Efficacy results from pivotal clinical trials with abatacept
A.L. Rozelle, M.C. Genovese
A.L. Rozelle, M.C. Genovese
CER3103
2007,25,5,Suppl.46
Pg. 0035-0045
Free to view
Quality of life in patients with rheumatoid arthritis: Does abatacept make a difference?
K. Michaud, C. Bombardier, P. Emery
K. Michaud, C. Bombardier, P. Emery
CER3104
2007,25,5,Suppl.46
Pg. 0046-0056
Free to view
Safety of T-cell co-stimulation modulation with abatacept in patients with rheumatoid arthritis
J. Sibilia, R. Westhovens
J. Sibilia, R. Westhovens